John R. Cashman

11.7k total citations · 2 hit papers
201 papers, 9.2k citations indexed

About

John R. Cashman is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, John R. Cashman has authored 201 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Molecular Biology, 44 papers in Pharmacology and 31 papers in Organic Chemistry. Recurrent topics in John R. Cashman's work include Pharmacogenetics and Drug Metabolism (37 papers), Pesticide Exposure and Toxicity (21 papers) and Cholinesterase and Neurodegenerative Diseases (21 papers). John R. Cashman is often cited by papers focused on Pharmacogenetics and Drug Metabolism (37 papers), Pesticide Exposure and Toxicity (21 papers) and Cholinesterase and Neurodegenerative Diseases (21 papers). John R. Cashman collaborates with scholars based in United States, Canada and Italy. John R. Cashman's co-authors include Jun Zhang, Connie J. Eaves, E. J. Corey, Christian Fankhauser, S. Christensen, Jerry D. Cohen, Joanne Chory, Detlef Weigel, Yunde Zhao and C Shih and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

John R. Cashman

199 papers receiving 9.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Role for Flavin Monooxygenase-Like Enzymes in Auxin Biosynthesis

2001 944 citations John R. Cashman et al. profile →
Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis.

1983 355 citations John R. Cashman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John R. Cashman United States	52	3.6k	1.9k	1.5k	1.2k	983	201	9.2k
Giorgio Bellomo Italy	56	4.9k 1.3×	1.2k 0.6×	824 0.6×	1.1k 0.9×	439 0.4×	243	13.6k
Luyong Zhang China	58	6.2k 1.7×	1.9k 1.0×	884 0.6×	1.8k 1.5×	853 0.9×	471	13.0k
Albrecht Wendel Germany	57	4.6k 1.3×	1.7k 0.9×	774 0.5×	1.0k 0.9×	634 0.6×	209	14.2k
Che‐Ming Teng Taiwan	64	7.6k 2.1×	1.7k 0.9×	2.4k 1.6×	1.0k 0.9×	2.5k 2.5×	489	16.0k
Wen‐Chi Hou Taiwan	53	7.6k 2.1×	620 0.3×	1.6k 1.1×	1.1k 0.9×	1.1k 1.1×	219	14.1k
Marc Diederich Luxembourg	65	6.8k 1.9×	569 0.3×	1.1k 0.7×	1.4k 1.2×	1.9k 1.9×	278	13.0k
Anil K. Jaiswal United States	58	10.8k 3.0×	1.3k 0.7×	987 0.7×	784 0.7×	543 0.6×	228	16.1k
David Ross United States	63	8.3k 2.3×	967 0.5×	640 0.4×	903 0.8×	486 0.5×	226	13.4k
Taeg Kyu Kwon South Korea	62	7.3k 2.0×	780 0.4×	993 0.7×	1.7k 1.4×	1.4k 1.4×	398	13.4k
Arthur I. Cederbaum United States	70	6.7k 1.9×	4.0k 2.1×	991 0.7×	1.3k 1.0×	999 1.0×	351	19.1k

Countries citing papers authored by John R. Cashman

Since Specialization

Citations

This map shows the geographic impact of John R. Cashman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Cashman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Cashman more than expected).

Fields of papers citing papers by John R. Cashman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Cashman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Cashman. The network helps show where John R. Cashman may publish in the future.

Co-authorship network of co-authors of John R. Cashman

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Cashman. A scholar is included among the top collaborators of John R. Cashman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Cashman. John R. Cashman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Joo Ho, et al.. (2024). Mechanistic Investigations on the Direct Regioselective Sulfonation of Gaseous Light Hydrocarbons by Sulfur Dioxide. ChemCatChem. 17(5).

Cashman, John R., et al.. (2024). Effect of PAWI-2 on pancreatic cancer stem cell tumors. Investigational New Drugs. 42(4). 353–360. 1 indexed citations

Ryan, Daniel A. J., Jiongjia Cheng, Koichi Masuda, & John R. Cashman. (2020). Role of Curcuminoids and Tricalcium Phosphate Ceramic in Rat Spinal Fusion. Tissue Engineering Part C Methods. 26(11). 577–589. 2 indexed citations

Cheng, Jiongjia, Mary A. Dwyer, Karl J. Okolotowicz, Mark Mercola, & John R. Cashman. (2018). A Novel Inhibitor Targets Both Wnt Signaling and ATM/p53 in Colorectal Cancer. Cancer Research. 78(17). 5072–5083. 22 indexed citations

Fandrick, Keith R., et al.. (2009). 2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors. Bioorganic & Medicinal Chemistry. 17(5). 2047–2068. 6 indexed citations

Cashman, John R. & Senait Ghirmai. (2009). Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression. Bioorganic & Medicinal Chemistry. 17(19). 6890–6897. 27 indexed citations

Volak, Laurie P., Senait Ghirmai, John R. Cashman, & Michael H. Court. (2008). Curcuminoids Inhibit Multiple Human Cytochromes P450, UDP-Glucuronosyltransferase, and Sulfotransferase Enzymes, whereas Piperine Is a Relatively Selective CYP3A4 Inhibitor. Drug Metabolism and Disposition. 36(8). 1594–1605. 161 indexed citations

Cashman, John R. & Jun Zhang. (2006). HUMAN FLAVIN-CONTAINING MONOOXYGENASES. The Annual Review of Pharmacology and Toxicology. 46(1). 65–100. 233 indexed citations

Zhang, Jun & John R. Cashman. (2005). QUANTITATIVE ANALYSIS OF FMO GENE mRNA LEVELS IN HUMAN TISSUES. Drug Metabolism and Disposition. 34(1). 19–26. 114 indexed citations

10.

Denton, Travis T., Xiaodong Zhang, & John R. Cashman. (2003). Nicotine-related alkaloids and metabolites as inhibitors of human cytochrome P-450 2A6. Biochemical Pharmacology. 67(4). 751–756. 55 indexed citations

11.

Cashman, John R., Brad Dykstra, Ian Clark‐Lewis, Allen Eaves, & Connie J. Eaves. (2002). Changes in the Proliferative Activity of Human Hematopoietic Stem Cells in NOD/SCID Mice and Enhancement of Their Transplantability after In Vivo Treatment with Cell Cycle Inhibitors. The Journal of Experimental Medicine. 196(9). 1141–1150. 42 indexed citations

12.

Glimm, Hanno, Wolfgang Eisterer, John R. Cashman, et al.. (2001). Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-β2 microglobulin–null mice. Journal of Clinical Investigation. 107(2). 199–206. 159 indexed citations

13.

Clement, Bernd, et al.. (2000). Reduction of Amphetamine Hydroxylamine and Other Aliphatic Hydroxylamines by Benzamidoxime Reductase and Human Liver Microsomes. Chemical Research in Toxicology. 13(10). 1037–1045. 14 indexed citations

14.

Borson, Soo, M Brush, Eric de Souza Gil, et al.. (1999). The Clock Drawing Test: Utility for Dementia Detection in Multiethnic Elders. The Journals of Gerontology Series A. 54(11). M534–M540. 106 indexed citations

15.

Lin, Jing & John R. Cashman. (1997). N-Oxygenation of Phenethylamine to the trans-Oxime by Adult Human Liver Flavin-Containing Monooxygenase and Retroreduction of Phenethylamine Hydroxylamine by Human Liver Microsomes. Journal of Pharmacology and Experimental Therapeutics. 282(3). 1269–1279. 34 indexed citations

16.

Berkman, Clifford E., et al.. (1997). Stereoselective inhibition of human butyrylcholinesterase by pbosphonotbiolate analogs of (+)- and (−)-cocaine. Biochemical Pharmacology. 54(11). 1261–1266. 15 indexed citations

17.

Cashman, John R., et al.. (1996). Pharmacokinetics and Molecular Detoxication. Environmental Health Perspectives. 104. 23–23. 10 indexed citations

18.

Stevens, Jeffrey, Lisa A. Shipley, John R. Cashman, Mark VandenBranden, & Steven Wrighton. (1993). Comparison of human and rhesus monkey in vitro phase I and phase II hepatic drug metabolism activities.. Drug Metabolism and Disposition. 21(5). 753–760. 62 indexed citations

19.

Cashman, John R., et al.. (1992). Specifically designed thiosteroids as active-site-directed probes for functional dissection of rat liver cytochrome P450 3A isozymes. Chemical Research in Toxicology. 5(1). 42–53. 7 indexed citations

20.

Cashman, John R.. (1985). Leukotriene Biosynthesis Inhibitors. Pharmaceutical Research. 2(6). 253–261. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact